HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
94.95
+0.19 (0.20%)
Dec 20, 2024, 4:00 PM EST - Market closed
HealthEquity Revenue
HealthEquity had revenue of $300.43M in the quarter ending October 31, 2024, with 20.55% growth. This brings the company's revenue in the last twelve months to $1.15B, up 18.47% year-over-year. In the fiscal year ending January 31, 2024, HealthEquity had annual revenue of $999.59M with 16.00% growth.
Revenue (ttm)
$1.15B
Revenue Growth
+18.47%
P/S Ratio
7.16
Revenue / Employee
$365,189
Employees
3,150
Market Cap
8.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2024 | 999.59M | 137.84M | 16.00% |
Jan 31, 2023 | 861.75M | 105.19M | 13.90% |
Jan 31, 2022 | 756.56M | 22.99M | 3.13% |
Jan 31, 2021 | 733.57M | 201.58M | 37.89% |
Jan 31, 2020 | 531.99M | 244.75M | 85.21% |
Jan 31, 2019 | Pro | Pro | Pro |
Jan 31, 2018 | Pro | Pro | Pro |
Jan 31, 2017 | Pro | Pro | Pro |
Jan 31, 2016 | Pro | Pro | Pro |
Jan 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walgreens Boots Alliance | 147.66B |
Henry Schein | 12.50B |
Bruker | 3.24B |
Teleflex | 3.03B |
Chemed | 2.38B |
Repligen | 633.51M |
Intra-Cellular Therapies | 613.73M |
Ascendis Pharma | 365.19M |
HQY News
- 4 days ago - HealthEquity Caps 2024 With Widespread Recognition For Its Workplace Excellence - GlobeNewsWire
- 11 days ago - HealthEquity Stock Falls on Disappointing Outlook - Investopedia
- 12 days ago - HealthEquity, Inc. (HQY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results - GlobeNewsWire
- 18 days ago - HealthEquity 2025 Benefits Trends Unveiled: Cost Transparency and Containment Take Center Stage for Administrators - GlobeNewsWire
- 4 weeks ago - HealthEquity: High Marks For Recent Profit Growth - Seeking Alpha
- 4 weeks ago - HealthEquity CMO Tia Padia Named "Visionary CMO" at MarCom Awards - GlobeNewsWire
- 5 weeks ago - HealthEquity Announces Retirement of CEO Jon Kessler; Scott Cutler Appointed Successor - GlobeNewsWire